Alnylam Pharmaceuticals (ALNY) PT Raised to $377 at Wells Fargo
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $278.09 -1.64%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $377.00 (from $376.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- CLSA Downgrades Subaru Corp. (7270:JP) (FUJHY) to Outperform (2)
- FSN Ecommerce Ventures (NYKAA:IN) PT Raised to INR340 at Kotak
- PolyPeptide Group AG (PPGN:SW) PT Raised to CHF45 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
